Mayo Clinic is collaborating on a study with Viome, a company transforming health through personalized nutrition based on individual biology to better understand the role of nutrition in disease and to explore the potential of Viome's AI-driven personalized diets in helping manage sleep disorders such as sleep apnea and obesity.
Understanding Microbiome
A person’s microbiome is the entire collection of microbes living in and on the body. The microbiome forms a living layer over your skin
Read More
LunaPBC Raises $4.6M to Fuel Community-Owned Genomic & Health Data Platform
LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, has raised $4.6 million from ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners. The latest round brings the company’s total funding to date to $7.6 million.
First Community-Owned Health & DNA Research Platform
Founded in 2017 on the belief that health data sharing and community ownership are the new philanthropy, LunaDNA is the first
Read More
Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database
uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 million in Series C funding. The round was led by OS Fund, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. Now, uBiome is mining its database (the world's largest human microbiome database) to discover new therapeutic targets, with an initial focus on
Read More
Ferring Acquires Microbiome Platform Rebiotix
Ferring Pharmaceuticals, a research-driven, specialty biopharmaceutical group has acquired Rebiotix Inc., a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to transform the treatment of challenging diseases. This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions for patients. Rebiotix’s RBX2660 is a non-antibiotic treatment in
Read More